PhRMA and Discern Health Collaborate To Publish PRO-PM Issue Brief

January 2018

The Pharmaceutical Research and Manufacturers of America (PhRMA) and Discern Health have published an issue brief on patient-reported outcome performance measures (PRO-PMs). The brief describes the current state of PRO-PMs and identifies opportunities for their development, endorsement, and implementation. Discern Vice President and lead author of the brief, Sarah Sampsel, notes, “There is intense interest in incorporating the patient perspective in assessing health care quality and in using this rich data source, yet gaps persist in incorporating PRO-PMs into clinical practice and payment programs, and moving beyond patient experience measures.”

Access the issue brief here.

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

September 2018 Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the mo...
Learn More

About

Capabilities

Contact Us

Insights

Guy D’Andrea Speaks About Innovative Payment Models

September 2018 Click here to view the VIDEO...
Learn More